Innate immunity in amyotrophic lateral sclerosis
- 1 November 2006
- journal article
- review article
- Published by Elsevier BV in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1762 (11-12), 1083-1093
- https://doi.org/10.1016/j.bbadis.2006.03.001
Abstract
No abstract availableKeywords
This publication has 136 references indexed in Scilit:
- Coincident thresholds of mutant protein for paralytic disease and protein aggregation caused by restrictively expressed superoxide dismutase cDNANeurobiology of Disease, 2005
- Like cops on the beat: the active role of resting microgliaTrends in Neurosciences, 2005
- Vaccination with autoantigen protects against aggregated β‐amyloid and glutamate toxicity by controlling microglia: effect of CD4+CD25+ T cellsEuropean Journal of Immunology, 2004
- Inflammatory mediators and growth factors in the spinal cord of G93A SOD1 ratsNeuroReport, 2004
- A therapeutic role for cyclooxygenase‐2 inhibitors in a transgenic mouse model of amyotrophic lateral sclerosisThe FASEB Journal, 2003
- Inhibition of cyclooxygenase-2 protects motor neurons in an organotypic model of amyotrophic lateral sclerosisAnnals of Neurology, 2000
- Central neuron–glial and glial–glial interactions following axon injuryProgress in Neurobiology, 1998
- Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosisNature, 1993
- Differentiation driven by granulocyte-macrophage colony-stimulating factor endows microglia with interferon-γ-independent antigen presentation functionJournal of Neuroimmunology, 1993
- Cytotoxicity of microgliaGlia, 1993